Among the down-regulated candidates (data not shown), only GNAI2 has been previously reported to be an activator of AKT [25]; therefore, we evaluated GNAI2 mRNA expressions in the six ovarian cancer cell lines by qRT-PCR (Figure 6B). The gene discussed is AKT1; the disease is ovarian cancer.